NMRD
Nemaura Medical Inc
Price:  
0.11 
USD
Volume:  
823,363.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NMRD WACC - Weighted Average Cost of Capital

The WACC of Nemaura Medical Inc (NMRD) is 9.1%.

The Cost of Equity of Nemaura Medical Inc (NMRD) is 11,199.00%.
The Cost of Debt of Nemaura Medical Inc (NMRD) is 7.00%.

Range Selected
Cost of equity 4,488.90% - 17,909.10% 11,199.00%
Tax rate 1.50% - 3.50% 2.50%
Cost of debt 7.00% - 7.00% 7.00%
WACC 7.8% - 10.4% 9.1%
WACC

NMRD WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 975 3197.18
Additional risk adjustments 0.0% 0.5%
Cost of equity 4,488.90% 17,909.10%
Tax rate 1.50% 3.50%
Debt/Equity ratio 4963.86 4963.86
Cost of debt 7.00% 7.00%
After-tax WACC 7.8% 10.4%
Selected WACC 9.1%

NMRD's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for NMRD:

cost_of_equity (11,199.00%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (975) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.